European Heart Journal vs Gastroenterology: Which Journal Should You Choose?

EHJ wants cardiovascular breadth. Gastroenterology wants digestive-disease depth plus field-level importance.

That difference matters because some crossover papers look large enough for a flagship journal in either field, but only one field actually needs the message as a first-order result.

EHJ's editorial guidance keep emphasizing general cardiology relevance, methodological rigor, and ESC-facing importance. Gastroenterology comparison's editorial guidance emphasize mechanistic GI work, liver and motility strength, and a willingness to carry more field-specific narrative than Gut or a general-medicine journal would.

So if your paper needs GI architecture to be convincing, Gastroenterology is often the better call. If it becomes stronger when converted into general cardiovascular language, EHJ is more plausible.

EHJ wins when the manuscript is fundamentally a cardiovascular paper.

That usually means:

• the primary outcome is cardiovascular
• the clinical implication is about cardiology management, risk, or prevention
• cardiologists are the natural first readers
• the digestive-disease context matters, but the cardiovascular consequence is the real headline

Examples:

• cardiovascular-risk studies in metabolic or inflammatory conditions when the message is for cardiology practice
• vascular-outcomes work where digestive-disease context is important, but not the central readership
• therapy-safety or risk-prediction papers that should influence broad cardiovascular interpretation

Gastroenterology wins when the paper is still best understood as a GI or hepatology paper.

That includes:

• digestive-disease studies with strong translational or mechanistic value
• liver and motility work that needs more field-specific narrative
• microbiome and inflammatory-disease papers that remain clearly GI-led
• clinical GI studies whose most important readers are still gastroenterologists

The practical point is that Gastroenterology can be the correct first target even for very ambitious papers if the field-specific audience is still the right one.

EHJ submission's editorial guidance makes clear that narrow, single-center, or limited-consequence work gets screened out early. That's relevant for organ-overlap papers because they can look important inside one specialty but still not broad enough for a flagship general cardiology journal.

comparison's editorial guidance already used in this branch notes that Gastroenterology is often more tolerant of longer mechanistic or layered narratives than Gut. That matters for crossover papers where the biology, digestive-disease framing, or liver context can't be compressed without weakening the paper.

The journal wants authors to explain how the work matters to cardiologists, often with explicit practice or guideline relevance. If that argument feels forced, the paper usually belongs somewhere else.

Being GI-shaped isn't enough. The paper still has to look like a flagship digestive-disease paper with enough importance to matter across the field.

• the paper is fundamentally cardiovascular
• general cardiologists are the primary readers
• the main result is about cardiovascular outcomes, risk, or treatment
• you can explain the paper's significance without depending on GI-specific context

That's the EHJ lane.

• the paper is fundamentally about digestive disease or liver disease
• GI specialists are the primary readers
• the paper needs GI-specific context to show why it matters
• the manuscript gets stronger, not weaker, when written for a specialty audience

That's the Gastroenterology lane.

If the study is mostly about microbiome biology or digestive-disease mechanisms, Gastroenterology is usually more natural. If the paper is really about cardiovascular risk prediction or management, EHJ becomes more realistic.

This can go either way. The real question is whether the message changes cardiology behavior or primarily helps hepatologists and GI clinicians interpret liver-related cardiovascular risk.

Some obesity and metabolic papers can look broad enough for cardiology if the cardiovascular endpoint is strong and central. Others are still much more coherent as GI or hepatology papers if the metabolic and digestive-disease logic drives the story.

This is a reasonable but selective cascade.

A paper rejected by EHJ can move to Gastroenterology if:

• the work is genuinely GI-led
• the rejection reflects breadth rather than quality
• the paper still looks strong enough for a flagship GI journal

The opposite route is less common. A paper rejected by Gastroenterology because it isn't GI-defined enough doesn't often improve by moving to EHJ unless the cardiovascular consequence was actually underemphasized from the start.

If the whole argument depends on the reader already caring about digestive disease, liver disease, or microbiome biology, EHJ gets much harder.

The journal can carry field-specific papers, but they still have to look important. A narrow GI study with weak top-line consequence will still struggle.

One recurring problem with crossover work is pretending that a specialty result is a field-wide cardiovascular event. EHJ editors are unlikely to reward that mismatch.

If the manuscript sounds "translational" but can't show a concrete clinical or mechanistic payoff, the story weakens quickly.

A strong EHJ first page tells a cardiology editor why this changes cardiovascular interpretation, care, or risk thinking right away.

A strong Gastroenterology first page tells a GI editor why this changes digestive-disease understanding, translational logic, or specialty practice right away.

If you can only make one of those first pages feel clean, that's usually your answer.

Try these finishing lines:

• "this changes how cardiologists interpret risk or treatment" points toward European Heart Journal
• "this changes how gastroenterologists or hepatologists interpret disease or treatment" points toward Gastroenterology

That sentence test is blunt, but it's often the fastest honest triage tool.

Send to European Heart Journal first if:

1. the manuscript is fundamentally cardiovascular
2. general cardiology is the natural audience
3. broad cardiovascular consequence is the main reason the paper matters
4. the digestive-disease context supports, but doesn't define, the message

Send to Gastroenterology first if:

1. the manuscript is fundamentally GI or liver focused
2. digestive-disease specialists are the natural audience
3. the paper needs specialty framing to be maximally convincing
4. the field-specific narrative is a strength, not a weakness